134 related articles for article (PubMed ID: 3113780)
21. Effect of calcium supplementation on urinary hydroxyproline in osteoporotic postmenopausal women.
Horowitz M; Need AG; Philcox JC; Nordin BE
Am J Clin Nutr; 1984 Jun; 39(6):857-9. PubMed ID: 6720619
[TBL] [Abstract][Full Text] [Related]
22. The prevention and management of post-menopausal osteoporosis.
Marshall DH; Horsman A; Nordin BE
Acta Obstet Gynecol Scand Suppl; 1977; 65():49-56. PubMed ID: 269626
[TBL] [Abstract][Full Text] [Related]
23. New approaches to the problems of osteoporosis.
Nordin BE; Need AG; Morris HA; Horowitz M
Clin Orthop Relat Res; 1985 Nov; (200):181-97. PubMed ID: 3905110
[TBL] [Abstract][Full Text] [Related]
24. Biologic effects of transdermal estradiol.
Chetkowski RJ; Meldrum DR; Steingold KA; Randle D; Lu JK; Eggena P; Hershman JM; Alkjaersig NK; Fletcher AP; Judd HL
N Engl J Med; 1986 Jun; 314(25):1615-20. PubMed ID: 3012339
[TBL] [Abstract][Full Text] [Related]
25. Calcitonin and postmenopausal osteoporosis.
Leggate J; Farish E; Fletcher CD; McIntosh W; Hart DM; Sommerville JM
Clin Endocrinol (Oxf); 1984 Jan; 20(1):85-92. PubMed ID: 6362926
[TBL] [Abstract][Full Text] [Related]
26. Estrogen replacement therapy by transdermal estradiol administration.
Laufer LR; DeFazio JL; Lu JK; Meldrum DR; Eggena P; Sambhi MP; Hershman JM; Judd HL
Am J Obstet Gynecol; 1983 Jul; 146(5):533-40. PubMed ID: 6407324
[TBL] [Abstract][Full Text] [Related]
27. Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women.
Selby PL; Peacock M
N Engl J Med; 1986 Jun; 314(23):1481-5. PubMed ID: 3754618
[TBL] [Abstract][Full Text] [Related]
28. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
29. A longitudinal study of bone-related biochemical changes at the menopause.
Nordin BE; WIshart JM; Clifton PM; McArthur R; Scopacasa F; Need AG; Morris HA; O'Loughlin PD; Horowitz M
Clin Endocrinol (Oxf); 2004 Jul; 61(1):123-30. PubMed ID: 15212654
[TBL] [Abstract][Full Text] [Related]
30. Parathyroid hormone and rates of bone formation are raised in perimenopausal rural Gambian women.
Aspray TJ; Yan L; Prentice A
Bone; 2005 Apr; 36(4):710-20. PubMed ID: 15780975
[TBL] [Abstract][Full Text] [Related]
31. Effects of a short course of estrogen on mineral metabolism in postmenopausal women.
Stock JL; Coderre JA; Mallette LE
J Clin Endocrinol Metab; 1985 Oct; 61(4):595-600. PubMed ID: 2993339
[TBL] [Abstract][Full Text] [Related]
32. Serum alkaline phosphatase during hormone treatment in early postmenopausal women. A model for establishing optimal prophylaxis and treatment in postmenopausal osteoporosis.
Christiansen C; Rødbro P; Tjellesen L
Acta Med Scand; 1984; 216(1):11-7. PubMed ID: 6385631
[TBL] [Abstract][Full Text] [Related]
33. Hormonal profiles in postmenopausal women after therapy with subcutaneous implants.
Thom MH; Collins WP; Studd JW
Br J Obstet Gynaecol; 1981 Apr; 88(4):426-33. PubMed ID: 6784745
[TBL] [Abstract][Full Text] [Related]
34. Effects of oestrogen deprivation on interleukin-6 production by peripheral blood mononuclear cells of postmenopausal women.
Rachoń D; Myśliwska J; Suchecka-Rachoń K; Wieckiewicz J; Myśliwski A
J Endocrinol; 2002 Feb; 172(2):387-95. PubMed ID: 11834456
[TBL] [Abstract][Full Text] [Related]
35. Effect of estrogen status on bone regulating hormones.
Zofková I; Kancheva RL
Bone; 1996 Sep; 19(3):227-32. PubMed ID: 8873963
[TBL] [Abstract][Full Text] [Related]
36. The effects of menopause and estrogen replacement therapy on the renal handling of calcium.
Adami S; Gatti D; Bertoldo F; Rossini M; Fratta-Pasini A; Zamberlan N; Facci E; Lo Cascio V
Osteoporos Int; 1992 Jul; 2(4):180-5. PubMed ID: 1611223
[TBL] [Abstract][Full Text] [Related]
37. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
Joseph F; Ahmad AM; Ul-Haq M; Durham BH; Whittingham P; Fraser WD; Vora JP
J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
[TBL] [Abstract][Full Text] [Related]
38. Comparison of transdermal to oral estradiol administration on hormonal and hepatic parameters in women with premature ovarian failure.
Steingold KA; Matt DW; DeZiegler D; Sealey JE; Fratkin M; Reznikov S
J Clin Endocrinol Metab; 1991 Aug; 73(2):275-80. PubMed ID: 1906893
[TBL] [Abstract][Full Text] [Related]
39. Prevention of bone loss by hormone replacement therapy is probably not due to stimulation of calcitonin secretion.
Fletcher CD; Farish E; Leggate J; Hart DM
Acta Endocrinol (Copenh); 1991 Apr; 124(4):353-6. PubMed ID: 2031433
[TBL] [Abstract][Full Text] [Related]
40. Effect of 1,25-dihydroxyvitamin D3 on biochemical indices of bone turnover in postmenopausal women.
Tjellesen L; Christiansen C; Rødbro P
Acta Med Scand; 1984; 215(5):411-5. PubMed ID: 6547563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
